Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: A systematic review,meta-analysis, and meta-regression analysis of cohort studies

American Journal of Epidemiology

Volumn 187, Issue 8, 2018, Pages 1817-1827

  Masarwa, Reem ^a,b   Levine, Hagai ^c   Gorelik, Einat ^a,d   Reif, Shimon ^b   Perlman, Amichai ^a   Matok, Ilan ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d MINISTRY OF HEALTH   (Israel)

Author keywords

Acetaminophen; Attention deficit hyperactivity disorder; Autistic spectrum disorder; Meta analysis; Offspring; Pregnancy; Risk

Indexed keywords

PARACETAMOL;

CHILD; CHILD HEALTH; COHORT ANALYSIS; DATABASE; LITERATURE REVIEW; MEDICINE; MENTAL DISORDER; META-ANALYSIS; POLLUTION EXPOSURE; PREGNANCY; REGRESSION ANALYSIS; RISK;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; COHORT ANALYSIS; DISEASE PREDISPOSITION; DRUG USE; EVIDENCE BASED MEDICINE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERACTIVITY; META ANALYSIS; OUTCOME ASSESSMENT; PRENATAL DRUG EXPOSURE; PROGENY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; FEMALE; MALE; PREGNANCY; PRENATAL EXPOSURE;

ACETAMINOPHEN; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; FEMALE; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 85052658942     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwy086     Document Type: Article

References (71)

1. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.
2. Rubin JD, Ferencz C, Loffredo C. Use of prescription and nonprescription drugs in pregnancy. The Baltimore-Washington Infant Study Group. J Clin Epidemiol. 1993;46(6):581-589.
3. Daw JR, Hanley GE, Greyson DL, et al. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20(9):895-902.
4. Glover DD, Amonkar M, Rybeck BF, et al. Prescription, overthe-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol. 2003;188(4):1039-1045.
5. Babb M, Koren G, Einarson A. Treating pain during pregnancy. Can Fam Physician. 2010;56(1):25-27.
6. Headley J, Northstone K, Simmons H, et al. Medication use during pregnancy: data fromthe Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol. 2004;60(5): 355-361.
7. MacGregor A. Management of migraine during pregnancy. Prog Neurol Psychiatry. 2009;13(5):21-24.
8. Amberbir A, Medhin G, Alem A, et al. The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth-cohort study. Am J Respir Crit Care Med. 2011;183(2):165-170.
9. Beasley R, Clayton T, Crane J, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet. 2008;372(9643):1039-1048.
10. Kristensen DM, Lesné L, Le Fol V, et al. Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis. Int J Androl. 2012;35(3):377-384.
11. Kristensen DM, Hass U, Lesné L, et al. Intrauterine exposure to mild analgesics is a risk factor for development of Male reproductive disorders in human and rat. Hum Reprod. 2011; 26(1):235-244.
12. Gurney J, Richiardi L, McGlynn KA, et al. Analgesia use during pregnancy and risk of cryptorchidism: a systematic review and meta-analysis. Hum Reprod. 2017;32(5): 1118-1129.
13. Ghanizadeh A. Acetaminophen may mediate oxidative stress and neurotoxicity in autism. Med Hypotheses. 2012;78(2):351.
14. Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313-320.
15. Avella-Garcia CB, Julvez J, Fortuny J, et al. Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms. Int J Epidemiol. 2016;45(6): 1987-1996.
16. Thompson JM, Waldie KE, Wall CR, et al. Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 2014; 9(9):e108210.
17. Stergiakouli E, Thapar A, Davey Smith G. Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding. JAMA Pediatr. 2016;170(10):964-970.
18. Liew Z, Ritz B, Virk J, et al. Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: a Danish National Birth Cohort study. Autism Res. 2016;9(9):951-958.
19. Posadas I, Santos P, Blanco A. Acetaminophen induces apoptosis in rat cortical neurons. PLoS One. 2010;5(12): e15360.
20. Weigand UW, Chou RC, Maulik D, et al. Assessment of biotransformation during transfer of propoxyphene and acetaminophen across the isolated perfused human placenta. Pediatr Pharmacol (New York). 1984;4(3):145-153.
21. Schultz ST, Klonoff-Cohen HS, Wingard DL, et al. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism. 2008;12(3):293-307.
22. Becker KG, Schultz ST. Similarities in features of autism and asthma and a possible link to acetaminophen use. Med Hypotheses. 2010;74(1):7-11.
23. Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313-320.
24. Hoover RM, Hayes VA, Erramouspe J. Association between prenatal acetaminophen exposure and future risk of attention deficit/hyperactivity disorder in children. Ann Pharmacother. 2015;49(12):1357-1361.
25. Rubin JD, Ferencz C, Loffredo C. Use of prescription and nonprescription drugs in pregnancy. The Baltimore-Washington Infant Study Group. J Clin Epidemiol. 1993;46(6):581-589.
26. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1-19.
27. Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children-United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439-1443.
28. Brandlistuen RE, Ystrom E, Nulman I, et al. Prenatal paracetamol exposure and child neurodevelopment: a siblingcontrolled cohort study. Int J Epidemiol. 2013;42(6): 1702-1713.
29. Streissguth AP, Treder RP, Barr HM, et al. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 1987;35(2):211-219.
30. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15): 2008-2012.
31. Transport Reporting Of Systematic Reviews and Meta-Analyses. PRISMA 2009 Checklist. 2009. http://www. prismastatement. org/documents/PRISMA 2009 checklist. pdf. Accessed February 20, 2017.
32. PROSPERO International Prospective Register of Systematic Reviews Web site. York, United Kingdom: Centre for Reviews and Dissemination. https://www. crd. york. ac. uk/Prospero. Accessed February 5, 2017.
33. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. The Ottawa Hospital Research Institute. http://www. ohri. ca/programs/clinical-epidemiology/ oxford. asp. Accessed February 28, 2017.
34. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605.
35. Viechtbauer W. Meta-Analysis Package for R. 2016. https:// cran. r-project. org/web/packages/metafor/metafor. pdf. Accessed March 12, 2017.
36. Borenstein M, Hedges L, Rothstein H. Meta-analysis fixed effect vs. random effects. 2007. https://www. meta-analysis. com/downloads/Meta-analysis%20fixed%20effect%20vs% 20random%20effects%20072607. pdf. Accessed April 11, 2018.
37. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.
38. Borenstein M. Effect sizes for continuous data. In: Cooper H, Hedges LV, Valentine JC, eds. The Handbook of Research Synthesis and Meta-Analysis. 2nd ed. New York, NY: Russell Sage Foundation; 2009. 221-235.
39. Del-Re A. Compute Effect Sizes. 2015. https://cran. r-project. org/web/packages/compute. es/compute. es. pdf. Accessed March 15, 2017.
40. McGraw KO, Wong SP. A common language effect size statistic. Psychol Bull. 1992;111(2):361-365.
41. Stevenson M. Tools for the Analysis of Epidemiological Data. 2016. https://cran. r-project. org/web/packages/epiR/epiR. pdf. Accessed March 15, 2017.
42. Valentine J, Cooper H. Effect size substantive interpretation guidelines: issues in the interpretation of effect sizes Washington DC: What Works Clearinghouse. 2003;http:// www. wmich. edu/sites/default/files/attachments/u58/2015/ Effect-Size-Substantive-Interpretation-Guidelines. pdf. Accessed April 11, 2018.
43. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
44. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002; 21(11):1559-1573.
45. Medicines and Healthcare Regulatory Association. Public Assessment Report Paracetamol 500mg Soluble Tablets. 2017. http://www. mhra. gov. uk/home/groups/par/documents/ websiteresources/con013975. pdf. Accessed November 3, 2017.
46. Colborn T. Neurodevelopment and endocrine disruption. Environ Health Perspect. 2004;112(9):944-949.
47. van Gelder MM, Schouten NP, Merkus PJ, et al. Using Webbased questionnaires and obstetric records to assess general health characteristics among pregnant women: a validation study. J Med Internet Res. 2015;17(6):e149.
48. Olesen C, Søndergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology. 2001; 12(5):497-501.
49. Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol. 2002;155(1):26-31.
50. Li Z, Ren A, Zhang L, et al. A population-based case-control study of risk factors for neural tube defects in four highprevalence areas of Shanxi Province, China. Paediatr Perinat Epidemiol. 2006;20(1):43-53.
51. Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696-1703.
52. Malm H. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome. Ther Drug Monit. 2012;34(6): 607-614.
53. Moretti ME, Bar-Oz B, Fried S, et al. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16(2):216-219.
54. Hornig M, Bresnahan MA, Che X, et al. Prenatal fever and autism risk. Mol Psychiatry. 2018;23(3):759-766.
55. Silasi M, Cardenas I, Kwon JY, et al. Viral infections during pregnancy. Am J Reprod Immunol. 2015;73(3):199-213.
56. Linnet KM, Dalsgaard S, Obel C, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry. 2003;160(6):1028-1040.
57. Biederman J, Milberger S, Faraone SV, et al. Familyenvironment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry. 1995;52(6):464-470.
58. Accornero VH, Amado AJ, Morrow CE, et al. Impact of prenatal cocaine exposure on attention and response inhibition as assessed by continuous performance tests. J Dev Behav Pediatr. 2007;28(3):195-205.
59. O'Connor TG, Heron J, Golding J, et al. Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry. 2002;180:502-508.
60. Neugebauer R, Hoek HW, Susser E. Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood. JAMA. 1999;282(5):455-462.
61. Ystrom E, Gustavson K, Brandlistuen RE, et al. Prenatal exposure to acetaminophen and risk of ADHD. Pediatrics. 2017;140(5):e20163840.
62. Spencer TJ, Biederman J, Mick E. Attention-deficit/ hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol. 2007;32(6):631-642.
63. Fasmer OB, Halmøy A, Oedegaard KJ, et al. Adult attention deficit hyperactivity disorder is associated with migraine headaches. Eur Arch Psychiatry Clin Neurosci. 2011;261(8): 595-602.
64. Sandin S, Hultman CM, Kolevzon A, et al. Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2012;51(5):477. e1-486. e1.
65. Cortese S. The neurobiology and genetics of attention-deficit/ hyperactivity disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol. 2012;16(5):422-433.
66. Gualtieri CT, Johnson LG. ADHD: is objective diagnosis possible? Psychiatry (Edgmont). 2005;2(11):44-53.
67. Puleo CM, Schmeidler J, Reichenberg A, et al. Advancing paternal age and simplex autism. Autism. 2012;16(4):367-380.
68. Eroglu S, Toprak S, Urgan O, et al. DSM-IV Diagnostic and Statistical Manual of Mental Disorder, Vol. 33. Washington, DC: American Psychiatric Organization; 2012:1-915.
69. Reade MC, Delaney A, Bailey MJ, et al. Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis-funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care. 2008;12(4):220.
70. Dreier JW, Andersen AM, Berg-Beckhoff G. Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring. Pediatrics. 2014;133(3):e674-e688.
71. Daw JR, Mintzes B, Law MR, et al. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin Ther. 2012;34(1):239. e2-249. e2.